Biological and Cognitive Marker of Neurodegeneration in Obstructive Sleep Apnea Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

136 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to investigate biomarkers and neurocognitive markers of neurodegenerative processes in obstructive sleep apnea patients.

The main questions the study aims to answer are:

* Does neurodegeneration assessed by neurobiological markers and neurocognitive test performance exists in obstructive sleep apnea?
* Are these neurodegenerative markers are associated with the adherence to clinical prescribed positive airway pressure therapy?

Newly diagnosed patients with obstructive sleep apnea will be observed during the use of clinical prescribed positive pressure therapy. Different study related investigations take place before and six months after treatment start.

Researchers will compare after six months the group of adherent treatment participants with the non-adherent treatment participants group to investigate if differences in the observed neurobiological or neurocognitive parameters exist.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Exercise Training on Cognitive Performance and Sympathetic Activity in Obstructive Sleep Apnea

NCT02289625

Obstructive Sleep Apnea

UNKNOWN NA

SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study

NCT06711159

Obstructive Sleep Apnea (OSA) Excessive Daytime Sleepiness

RECRUITING

Impact of Severe Obstructive Sleep Apnea-Hypopnea Syndrome on Auditory-Cognitive Processing

NCT07039500

Obstructive Sleep Apnea Auditory Processing Disorder

RECRUITING

Evaluation of Potential Biomarkers for Obstructive Sleep Apnea and the Effect of Positive Pressure Treatment

NCT01976052

Obstructive Sleep Apnea

COMPLETED

Investigating the Neuropathology of Obstructive Sleep Apnoea

NCT02967536

Obstructive Sleep Apnoea Inflammation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Apnea, Obstructive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Newly diagnosed sleep apnea patients, starting clinical prescribed positive airway pressure therapy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* newly diagnosed obstructive sleep apnea
* clinical indication for start of positive airwas pressure therapy
* Age older than 18 years

Exclusion Criteria

* neurodegenerative disease
* Multiple sclerosis
* Stroke within last 3 months
* Brain injury within last 3 months
* MoCA \< 21 points
* higher degree chonic kidney disease (lower than 30 mL/min)
* regular use of sleep pills (e.g. Zopiclon, Mirtazapin, Daridorexant)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No